New anti-inflammatory/anti-arthritic heterocyclic bisphosphonates

Phosphorus, Sulfur and Silicon and Related Elements

Volumn 109, Issue 1-4, 1996, Pages 229-232

  Nugent, Richard A ^a   Dunn, Colin J ^a   Staite, Nigel D ^a   Murphy, Michael J ^a   Schlachter, Stephen T ^a   Aspar, Danielle G ^a   Shields, Sharon K ^a   Galinet, Louise A ^a  

^a PFIZER INC   (United States)

Author keywords

Antiarthritic; Antigen induced arthritis; Antiinflammatory; Bisphosphonate esters; Delayed type hypersensitivity

Indexed keywords

EID: 0041595659     PISSN: 10426507     EISSN: None     Source Type: Journal    
DOI: 10.1080/10426509608545132     Document Type: Article

References (9)

1. A.D. Geddes, S.M. D'Souza, F.H. Ebetino, and K.J. Ibbotson, in Bone and Mineral Research/8 (Elsevier Science, New York, 1994).
2. R.A. Nugent, S.T. Schlachter, M. Murphy, C.J. Dunn, N.D. Staite, L.A. Galinet, S.K. Shields, H. Wu, D.G. Aspar, and K.A. Richard, J. Med. Chem., 34, 4449-4455 (1994).
3. C.R. Degenhardt and C.D. Burdsall, J. Org. Chem., 51, 3488-3490 (1986).
4. C.J. Dunn, A.J. Gibbons, and S.K. Miller, Agents Actions, 27, 365-368 (1989).
5. C.J. Dunn, L.A. Galinet, A.J. Gibbons, and S.K. Shields, Int. J. Immunopharmacol. 12, 899-904 (1990).
6. All drugs were administered po. The data reported represent the % inhibition of granuloma dry weight.
7. I.M. Hunneyball, M. J. Crossley, and M. Spowage, Agents Actions, 18, 384-393 (1986).
8. A.S. Said Ghozlan, Pharmazie, 46, 352-353 (1991).
9. R. Gompper, Chem. Ber., 93, 198-209 (1960).